Publication | Closed Access

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

MedicineHormonal ReceptorOligonucleotideAntisense OligonucleotideAntisense TherapyProstatic DiseasePharmacologyRadiation OncologyHuman Androgen ReceptorTumor BiologyEndocrine-related Cancer